All stock lists
Unlock the score
Stoneridge Inc (New York Stock Exchange:SRI)
US · Delayed Price · Currency is USD
Consumer Cyclical · Auto - Parts
5.81-0.03 (-0.51%)
Market cap
$166M
Insider Score
Health Score
Analyst consensus
Listed since
Oct 10, 1997
Website
Insider Score
/ 100
SRI Insider Score
STONERIDGE INC has a live Insider Score.
Scored on 2 qualifying trades from 2 insiders in the last 90 days.
Financial Health Score
Sound
From SRI’s reported statements · Q2 2026 (trailing 12 months)
Profitability3 / 20
Loses money on what it sells.
- Revenue
- $757.7M
- Net income
- -$109.3M
- Net margin
- -14.4%
Leverage9 / 20
A manageable debt load.
- Total debt
- $156.9M
- Cash
- $71.5M
- Debt / equity
- 1.05
Liquidity19 / 20
Comfortably covers what is due within a year.
- Current assets
- $344.3M
- Current liabilities
- $182.1M
- Current ratio
- 1.89
Cash generation11 / 20
Roughly cash-neutral.
- Operating cash flow
- $10.1M
- Free cash flow
- -$7.9M
- FCF margin
- -1.0%
Dilution & runway19 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 28.2M
- Share growth (1y)
- 1.6%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
SRI Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 181.38 M | 160.85 M | 205.15 M | 210.27 M | 227.95 M | 217.89 M |
| Revenue Growth (YoY) | -20.43 % | -26.18 % | -6.00 % | -1.67 % | -3.84 % | -8.89 % |
| Cost of Revenue | 144.55 M | 125.89 M | 173.10 M | 165.60 M | 178.98 M | 170.79 M |
| Gross Profit | 36.83 M | 34.96 M | 32.06 M | 44.67 M | 48.98 M | 47.10 M |
| SG&A Expense | 26.06 M | 32.53 M | 26.56 M | 31.47 M | 34.80 M | 31.62 M |
| R&D Expense | 11.96 M | 11.40 M | 11.54 M | 13.74 M | 17.34 M | 17.58 M |
| Operating Expenses | 38.02 M | 43.93 M | 38.10 M | 45.21 M | 52.14 M | 49.20 M |
| Operating Income | -1.19 M | -8.98 M | -6.04 M | -540.00 K | -3.16 M | -2.10 M |
| Pretax Income | -2.72 M | -13.36 M | -30.99 M | -9.71 M | -9.12 M | -5.63 M |
| Tax Provision | 2.56 M | 1.22 M | 45.92 M | -343.00 K | 244.00 K | 1.56 M |
| Net Income | -5.28 M | -17.76 M | -76.91 M | -9.37 M | -9.36 M | -7.20 M |
| EPS (Basic) | -0.19 | -0.64 | -2.76 | -0.33 | -0.34 | -0.26 |
| EPS (Diluted) | -0.19 | -0.64 | -2.76 | -0.33 | -0.34 | -0.26 |
| Shares Outstanding | 28.24 M | 27.90 M | 27.86 M | 27.78 M | 27.79 M | 27.68 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.